Abstract

Aim:n-Propanol extracts from fresh, boiled, and fermented seeds were studied to evaluate their neuroprotective effects in a Parkinson’s disease (PD) rat model, based on the total number of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc).Materials and Methods:Rats were induced with paraquat dichloride at a dosage of 7 mg/kg BW intraperitoneally twice a week and at the same time supplemented with extract at a dosage of 70 mg/kg BW orally every day for 3 weeks. On the 24th day, all rats were perfused and fixed with 4% paraformaldehyde. The left part of the SNpc was processed for immunohistochemical staining with tyrosine hydroxylase (TH)-antibody. The total number of DA neurons in SNpc was evaluated with a stereological method.Results:TH-immunoreactive cells found in the SNpc were identified as DA neurons. The average total number of DA neurons in the SNpc increased significantly in the PD rat model that was given an n-propanol extract of boiled and fermented seeds compared with a control PD rat model. Surprisingly, there was no significant difference in the average total number of DA neurons in SNpc between the PD rat model that was given n-propanol extract of fresh seeds and the control PD rat model.Conclusion:n-Propanol extract of boiled and fermented seeds could produce a higher neuroprotective effect against DA neuron than fresh seeds in a PD rat model.

Highlights

  • At present, human life expectancy is increasing

  • The average total number of DA neurons in the substantia nigra pars compacta (SNpc) increased significantly in the Parkinson’s disease (PD) rat model that was given an n-propanol extract of boiled and fermented seeds compared with a control PD rat model

  • There was no significant difference in the average total number of DA neurons in SNpc between the PD rat model that was given n-propanol extract of fresh seeds and the control PD rat model

Read more

Summary

Introduction

Based on data from the World Health Organization, the number of people aged over 65 will have risen from 390 million in 1997 to 800 million in 2025 [1]. Aging of the population is followed by an increasing number of patients with degenerative diseases. Mortality from such neurodegenerative diseases as Parkinson’s disease (PD), Alzheimer’s, and cerebrovascular disease will increase, contrary to that of infectious diseases such as tetanus, meningitis, and Japanese encephalitis [2]. PD was first reported by James Parkinson in 1817 in London, but the concept of the disease continued to evolve the present level of understanding. PD is characterized by loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) and the presence

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call